ImmunoGen, Inc. (IMGN)
NASDAQ: IMGN · IEX Real-Time Price · USD
5.31
+0.04 (0.76%)
At close: Aug 10, 2022 4:00 PM
5.16
-0.15 (-2.82%)
After-hours:
Aug 10, 2022 5:48 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
|
69.86 | 132.3 | 82.27 | 53.45 | 115.45 | 60 | 85.54 | 59.9 | 35.54 | 16.36 | Upgrade
|
| Revenue Growth (YoY)
|
-47.20% | 60.81% | 53.93% | -53.71% | 92.41% | -29.86% | 42.82% | 68.55% | 117.25% | -15.27% | Upgrade
|
| Gross Profit
|
69.86 | 132.3 | 82.27 | 53.45 | 115.45 | 60 | 85.54 | 59.9 | 35.54 | 16.36 | Upgrade
|
| Selling, General & Admin
|
43.81 | 38.6 | 38.49 | 36.75 | 33.91 | 36.92 | 28.23 | 24.47 | 21.47 | 20.42 | Upgrade
|
| Research & Development
|
151.12 | 114.59 | 114.52 | 174.46 | 139.74 | 148.08 | 111.77 | 106.96 | 87.07 | 69.19 | Upgrade
|
| Other Operating Expenses
|
0 | 1.49 | 21.43 | 3.69 | 0.78 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses
|
194.93 | 154.68 | 174.44 | 214.9 | 174.43 | 184.99 | 140 | 131.43 | 108.54 | 89.61 | Upgrade
|
| Operating Income
|
-125.07 | -22.38 | -92.17 | -161.45 | -58.98 | -124.99 | -54.46 | -71.53 | -73.01 | -73.26 | Upgrade
|
| Interest Expense / Income
|
0.05 | 0.1 | 0.1 | 0.1 | 3.04 | 0.14 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Expense / Income
|
14.18 | 21.9 | 11.87 | 7.3 | 33.99 | 19.69 | 6.28 | -0.17 | -0.2 | 0.06 | Upgrade
|
| Pretax Income
|
-139.3 | -44.37 | -104.13 | -168.84 | -96.01 | -144.82 | -60.74 | -71.36 | -72.81 | -73.32 | Upgrade
|
| Net Income
|
-139.3 | -44.37 | -104.13 | -168.84 | -96.01 | -144.82 | -60.74 | -71.36 | -72.81 | -73.32 | Upgrade
|
| Net Income Common
|
-139.3 | -44.37 | -104.13 | -168.84 | -96.01 | -144.82 | -60.74 | -71.36 | -72.81 | -73.32 | Upgrade
|
| Shares Outstanding (Basic)
|
206 | 176 | 148 | 140 | 98 | 87 | 86 | 85 | 84 | 77 | Upgrade
|
| Shares Outstanding (Diluted)
|
206 | 176 | 148 | 140 | 98 | 87 | 86 | 85 | 84 | 77 | Upgrade
|
| Shares Change
|
17.03% | 18.77% | 5.98% | 42.70% | 12.75% | 1.09% | 0.65% | 1.69% | 9.44% | 11.46% | Upgrade
|
| EPS (Basic)
|
-0.68 | -0.25 | -0.70 | -1.21 | -0.98 | -1.67 | -0.71 | -0.83 | -0.87 | -0.95 | Upgrade
|
| EPS (Diluted)
|
-0.68 | -0.25 | -0.70 | -1.21 | -0.98 | -1.67 | -0.71 | -0.83 | -0.87 | -0.95 | Upgrade
|
| Free Cash Flow Per Share
|
-0.83 | -0.44 | -0.60 | -1.23 | 0.07 | -1.55 | -0.73 | -0.72 | -0.76 | -0.48 | Upgrade
|
| Gross Margin
|
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin
|
-179.04% | -16.92% | -112.04% | -302.08% | -51.09% | -208.31% | -63.66% | -119.42% | -205.46% | -447.86% | Upgrade
|
| Profit Margin
|
-199.42% | -33.54% | -126.57% | -315.91% | -83.17% | -241.35% | -71.01% | -119.15% | -204.90% | -448.24% | Upgrade
|
| Free Cash Flow Margin
|
-244.57% | -59.04% | -108.06% | -321.20% | 5.66% | -224.75% | -73.32% | -103.24% | -180.30% | -227.40% | Upgrade
|
| EBITDA
|
-137.24 | -42.18 | -100.01 | -161.34 | -87.01 | -139.35 | -55.23 | -66.77 | -68.17 | -68.69 | Upgrade
|
| EBITDA Margin
|
-196.46% | -31.88% | -121.56% | -301.87% | -75.37% | -232.25% | -64.56% | -111.47% | -191.84% | -419.92% | Upgrade
|
| Depreciation & Amortization
|
2.02 | 2.1 | 4.03 | 7.41 | 5.96 | 5.33 | 5.51 | 4.6 | 4.64 | 4.63 | Upgrade
|
| EBIT
|
-139.26 | -44.28 | -104.04 | -168.75 | -92.97 | -144.68 | -60.74 | -71.36 | -72.81 | -73.32 | Upgrade
|
| EBIT Margin
|
-199.35% | -33.47% | -126.46% | -315.74% | -80.53% | -241.12% | -71.01% | -119.15% | -204.90% | -448.24% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).